2022.07.22
License Agreement Has Been Entered into with KarisBio, Inc.
License-Out
We have executed a non-exclusive therapeutic use license agreement with KarisBio, Inc. (Republic of Korea) for commercial use of the patents on iPS cell technologies licensed to us by Kyoto University.